These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8995081)

  • 21. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.
    Saleh HA; Jackson H; Banerjee M
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):175-82. PubMed ID: 10981868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
    Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
    J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
    Demirbaş S; Sücüllü I; Yildirim S; Celenk T
    Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix.
    Rajkumar T; Rajan S; Baruah RK; Majhi U; Selvaluxmi G; Vasanthan A
    Eur J Gynaecol Oncol; 1998; 19(6):556-60. PubMed ID: 10215440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
    Kaklamanis L; Savage A; Whitehouse R; Doussis-Anagnostopoulou I; Biddolph S; Tsiotos P; Mortensen N; Gatter KC; Harris AL
    Br J Cancer; 1998 Jun; 77(11):1864-9. PubMed ID: 9667660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.
    Ilyas M; Hao XP; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Bodmer WF; Talbot IC
    Gut; 1998 Sep; 43(3):383-7. PubMed ID: 9863484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 and BCL-2 as prognostic markers in endometrial carcinoma.
    Appel ML; Edelweiss MI; Fleck J; Rivero LF; Rivoire WA; Mônego HI; Dos Reis R
    Pathol Oncol Res; 2008 Mar; 14(1):23-30. PubMed ID: 18398703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
    Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
    Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.
    Klatka J
    Eur Arch Otorhinolaryngol; 2001 Dec; 258(10):537-41. PubMed ID: 11829192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical study of 49 cutaneous melanomas: p53, PCNA, Bcl-2 expression and multidrug resistance.
    Loggini B; Rinaldi I; Pingitore R; Cristofani R; Castagna M; Barachini P
    Tumori; 2001; 87(3):179-86. PubMed ID: 11504374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas.
    Ohshio G; Suwa H; Imamura T; Yamaki K; Tanaka T; Hashimoto Y; Imamura M
    Scand J Gastroenterol; 1998 May; 33(5):535-9. PubMed ID: 9648995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
    Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
    World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
    Wolf HK; Stöber C; Hohenfellner R; Leissner J
    Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.